News RSS Bioethics News.

04/18/2018

Drug companies get tax windfall, but they’re not reducing prescription prices

External Link - Source: USA Today

Drug prices are a top pocketbook issue for Americans. President Trump understood that and campaigned on promises to bring down the cost of prescriptions. You’d think the massive tax cut he signed into law in December would be the perfect opportunity for drug companies to take some of their windfall and bring down those prices. But a new analysis shows that so far, you’d be wrong.

This entry was posted in Pharmaceuticals and tagged . Bookmark the permalink.